Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Allouchery, Marion
22  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Second-degree burn induced by high-concentration topical ca..:

Trin, Kilian ; Perino, Justine ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1111/papr.13175.  , 2023
Link: https://hal.science/hal-..
 
?
2

Second-degree burn induced by high-concentration topical ca..:

Trin, Kilian ; Perino, Justine ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1111/papr.13175.  , 2023
Link: https://hal.science/hal-..
 
?
3

Safety of Immune Checkpoint Inhibitor Resumption after Inte..:

Allouchery, Marion ; Beuvon, Clément ; Pérault-Pochat, Marie-Christine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870725/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Second-degree burn induced by high-concentration topical ca..:

TRIN, Kilian ; PERINO, Justine ; ALLOUCHERY, Marion...
1533-2500 (Electronic) 1530-7085 (Linking).  , 2022
Link: https://oskar-bordeaux.f..
 
?
5

Second‐degree burn induced by high‐concentration topical ca..:

Trin, Kilian ; Perino, Justine ; Allouchery, Marion...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099465/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Ca..:

Martin, Mickaël ; Nguyen, Hoan-My ; Beuvon, Clément...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599380/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmac..:

ALLOUCHERY, Marion ; TOMOWIAK, Cecile ; LOMBARD, Thomas..
1663-9812 (Print) 1663-9812 (Linking).  , 2021
Link: https://oskar-bordeaux.f..
 
?
8

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmac..:

Allouchery, Marion ; Tomowiak, Cécile ; Lombard, Thomas..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580940/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Safety of immune checkpoint inhibitor rechallenge after dis..:

Allouchery, Marion ; Lombard, Thomas ; Martin, Mickael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768965/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Liquid formulation of ifosfamide increased risk of encephal..:

Hillaire-Buys, Dominique ; Mousset, Mégane ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2019.08.001.  , 2019
Link: https://hal.umontpellier..
 
?
11

Liquid formulation of ifosfamide increased risk of encephal..:

Hillaire-Buys, Dominique ; Mousset, Mégane ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2019.08.001.  , 2019
Link: https://hal.umontpellier..
 
?
12

Liquid formulation of ifosfamide increased risk of encephal..:

Hillaire-Buys, Dominique ; Mousset, Mégane ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2019.08.001.  , 2019
Link: https://hal.umontpellier..
 
?
13

Liquid formulation of ifosfamide increased risk of encephal..:

Hillaire-Buys, Dominique ; Mousset, Mégane ; Allouchery, Marion...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.therap.2019.08.001.  , 2019
Link: https://hal.umontpellier..
 
?
14

DRESS Syndrome sous rifampicine, isoniazide, pyrazinamide e..:

Allouchery, Marion
dumas-01432504.  , 2016
Link: https://dumas.ccsd.cnrs...
 
?
15

DRESS Syndrome sous rifampicine, isoniazide, pyrazinamide e..:

Allouchery, Marion
dumas-01432504.  , 2016
Link: https://dumas.ccsd.cnrs...
 
1-15